Adjuvant zoledronic acid and letrozole plus ovarian function suppression in premenopausal breast cancer: HOBOE phase 3 randomised trial

MLA

Emanuela Rossi, et al. “Adjuvant Zoledronic Acid and Letrozole plus Ovarian Function Suppression in Premenopausal Breast Cancer: HOBOE Phase 3 Randomised Trial.” European Journal of Cancer (Oxford, England : 1990), vol. 118, Feb. 2019. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....16989de51f471ccf27840bdb59d88cf2&authtype=sso&custid=ns315887.

APA

Emanuela Rossi, Francesca Di Rella, Carlo Putzu, Francesco Perrone, Rossella Lauria, Lucia Del Mastro, Gennaro Daniele, Vittorio Simeon, Vincenza Tinessa, Ermelinda De Maio, Sabino De Placido, G. Landi, Sandro Barni, Francesco Nuzzo, Saverio Cinieri, Giovanni Iodice, Andrea de Matteis, Nicola Normanno, A. Fabbri, … Michelino De Laurentiis. (2019). Adjuvant zoledronic acid and letrozole plus ovarian function suppression in premenopausal breast cancer: HOBOE phase 3 randomised trial. European Journal of Cancer (Oxford, England : 1990), 118.

Chicago

Emanuela Rossi, Francesca Di Rella, Carlo Putzu, Francesco Perrone, Rossella Lauria, Lucia Del Mastro, Gennaro Daniele, et al. 2019. “Adjuvant Zoledronic Acid and Letrozole plus Ovarian Function Suppression in Premenopausal Breast Cancer: HOBOE Phase 3 Randomised Trial.” European Journal of Cancer (Oxford, England : 1990) 118 (February). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....16989de51f471ccf27840bdb59d88cf2&authtype=sso&custid=ns315887.